JW (Cayman) Therapeutics JWCTF Stock
JW (Cayman) Therapeutics Price Chart
JW (Cayman) Therapeutics JWCTF Financial and Trading Overview
| JW (Cayman) Therapeutics stock price | 0.45 USD |
| Previous Close | 0.36 USD |
| Open | 0.36 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.36 - 0.36 USD |
| 52 Week Range | 0.0004 - 1.07 USD |
| Volume | 300 USD |
| Avg. Volume | 681 USD |
| Market Cap | 164.29M USD |
| Beta (5Y Monthly) | 1.982158 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.21 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
JWCTF Valuation Measures
| Enterprise Value | -965959616 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.127565 |
| Price/Book (mrq) | 0.06107428 |
| Enterprise Value/Revenue | -6.63 |
| Enterprise Value/EBITDA | 1.534 |
Trading Information
JW (Cayman) Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.982158 |
| 52-Week Change | -64.070% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.07 USD |
| 52 Week Low | 0.0004 USD |
| 50-Day Moving Average | 0.42 USD |
| 200-Day Moving Average | 0.5 USD |
JWCTF Share Statistics
| Avg. Volume (3 month) | 681 USD |
| Avg. Daily Volume (10-Days) | 78 USD |
| Shares Outstanding | 411.04M |
| Float | 303.52M |
| Short Ratio | N/A |
| % Held by Insiders | 34.09% |
| % Held by Institutions | 4.17% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -478.49% |
| Gross Margin | 40.32% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.75% |
| Return on Equity (ttm) | -32.89% |
Income Statement
| Revenue (ttm) | 145.7M USD |
| Revenue Per Share (ttm) | 0.36 USD |
| Quarterly Revenue Growth (yoy) | 158.80% |
| Gross Profit (ttm) | 58.76M USD |
| EBITDA | -629526976 USD |
| Net Income Avi to Common (ttm) | -846134976 USD |
| Diluted EPS (ttm) | -0.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.39B USD |
| Total Cash Per Share (mrq) | 3.47 USD |
| Total Debt (mrq) | 279.13M USD |
| Total Debt/Equity (mrq) | 11.86 USD |
| Current Ratio (mrq) | 4.778 |
| Book Value Per Share (mrq) | 5.883 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -536721984 USD |
| Levered Free Cash Flow (ttm) | -428104256 USD |
Profile of JW (Cayman) Therapeutics
| Country | United States |
| State | N/A |
| City | Shanghai |
| Address | Building B |
| ZIP | N/A |
| Phone | 86 21 5078 3699 |
| Website | https://www.jwtherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 528 |
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, engages in the research and development, manufacturing, and marketing of anti-tumor drugs in the People's Republic of China. It offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is Carteyva (relmacabtagene autoleucel), an anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy for the treatment of a range of hematological cancers. The company's pipeline products include JWCAR129, an autologous CAR-T therapy for the treatment of multiple myeloma; JWATM204, a TCR T-cell therapy candidate for the treatment of HCC; and JWATM203, an autologous T-cell receptor mimic T-cell therapy targeting alpha-fetoprotein for the treatment of hepatocellular carcinoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.
Q&A For JW (Cayman) Therapeutics Stock
What is a current JWCTF stock price?
JW (Cayman) Therapeutics JWCTF stock price today per share is 0.45 USD.
How to purchase JW (Cayman) Therapeutics stock?
You can buy JWCTF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for JW (Cayman) Therapeutics?
The stock symbol or ticker of JW (Cayman) Therapeutics is JWCTF.
Which industry does the JW (Cayman) Therapeutics company belong to?
The JW (Cayman) Therapeutics industry is Biotechnology.
How many shares does JW (Cayman) Therapeutics have in circulation?
The max supply of JW (Cayman) Therapeutics shares is 416.23M.
What is JW (Cayman) Therapeutics Price to Earnings Ratio (PE Ratio)?
JW (Cayman) Therapeutics PE Ratio is now.
What was JW (Cayman) Therapeutics earnings per share over the trailing 12 months (TTM)?
JW (Cayman) Therapeutics EPS is -0.21 USD over the trailing 12 months.
Which sector does the JW (Cayman) Therapeutics company belong to?
The JW (Cayman) Therapeutics sector is Healthcare.